Company Valuation: Laboratoires Euromedis

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 37.64 31.27 14.38 15.54 12.54 11.15
Change - -16.9% -54.01% 8.08% -19.35% -11.06%
Enterprise Value (EV) 1 39.66 14.94 0.4192 25.56 20.57 0.5843
Change - -62.32% -97.19% 5,997% -19.52% -97.16%
P/E 1.8x 16.7x -2.37x 1.16x -2.05x -84.9x
PBR 1.05x 0.77x 0.41x 0.67x 0.76x 0.68x
PEG - -0.2x 0x -0x 0x 0.9x
Capitalization / Revenue 0.19x 0.28x 0.27x 0.46x 0.34x 0.27x
EV / Revenue 0.21x 0.13x 0.01x 0.75x 0.57x 0.01x
EV / EBITDA 1.23x 2.88x -0.1x -5.76x 33.3x 1.09x
EV / EBIT 1.28x 3.57x -0.08x -4.6x 51.9x 1.86x
EV / FCF 8.88x 0.88x 0.58x - - -
FCF Yield 11.3% 114% 173% - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 7.609 0.63 -2.029 4.602 -2.148 -0.0461
Distribution rate - - - - - -
Net sales 1 193.4 111.9 54.18 34.07 36.41 41.06
EBITDA 1 32.14 5.196 -4.013 -4.435 0.6186 0.5337
EBIT 1 30.99 4.182 -5.135 -5.557 0.3967 0.3142
Net income 1 22.66 2.256 -5.933 13.11 -6.108 -0.1318
Net Debt 1 2.02 -16.33 -13.96 10.02 8.037 -10.57
Reference price 2 13.700 10.500 4.810 5.320 4.400 3.920
Nbr of stocks (in thousands) 2,747 2,978 2,990 2,922 2,849 2,844
Announcement Date 6/3/21 4/29/22 4/28/23 5/5/25 5/5/25 4/30/26
1EUR in Million2EUR
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 16.53M
33.46x4.49x17.25x2.2% 202B
21.15x3.63x12.76x3.19% 119B
17.42x0.2x12.74x0.75% 60.69B
30.35x7.55x19.27x1.31% 52.38B
37x3.53x12.12x2.04% 52.3B
37.01x6.52x20.46x-.--% 34.85B
44.97x1.28x11.71x0.17% 30.06B
41.17x7.21x25.89x0.26% 24.85B
19.84x3.06x11.16x1.45% 23.84B
Average 31.38x 4.16x 15.93x 1.26% 60.03B
Weighted average by Cap. 29.99x 4.08x 15.65x 1.82%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. ALEMG Stock
  4. Valuation Laboratoires Euromedis